Leukocare AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Leukocare AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014169
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting individual needs of target proteins; development of spray drying and spray freeze drying processes; and development of customized lyophilization protocols. It offers development of vaccine formulation; coupling of biological compounds to functionalize surfaces; and establishment of biological read outs. Leukocare provides its services in the areas of physiology, biochemistry, biophysics, pharmaceutical technology, pharmacology, immunology, chemistry and medical engineering. Leukocare is headquartered in Munich, Germany.

Leukocare AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Leukocare AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Leukocare AG, Medical Devices Deals, 2011 to YTD 2017 9
Leukocare AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Leukocare AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 11
Rentschler Biotech Enters into Agreement with Leukocare 12
Leukocare Enters into Agreement with Technical University of Munich 13
Licensing Agreements 14
PaxVax Enters into Licensing Agreement with Leukocare 14
LEUKOCARE Enters into Licensing Agreement with Animal Health Provider for Veterinarian Vaccine 15
Leukocare AG – Key Competitors 16
Leukocare AG – Key Employees 17
Leukocare AG – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Leukocare AG, Pharmaceuticals & Healthcare, Key Facts 2
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Leukocare AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Leukocare AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Leukocare AG, Deals By Therapy Area, 2011 to YTD 2017 8
Leukocare AG, Medical Devices Deals, 2011 to YTD 2017 9
Leukocare AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Trillium Diagnostics Enters Into Licensing Agreement With Leukocare For Sepsis Dx 11
Rentschler Biotech Enters into Agreement with Leukocare 12
Leukocare Enters into Agreement with Technical University of Munich 13
PaxVax Enters into Licensing Agreement with Leukocare 14
LEUKOCARE Enters into Licensing Agreement with Animal Health Provider for Veterinarian Vaccine 15
Leukocare AG, Key Competitors 16
Leukocare AG, Key Employees 17

★海外企業調査レポート[Leukocare AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iPass Inc.:企業の戦略的SWOT分析
    iPass Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Gordon Ramsay Holdings Limited:企業の戦略・SWOT・財務情報
    Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Repligen Corp (RGEN):企業の財務・戦略的SWOT分析
    Summary Repligen Corp (Repligen) operates as a bioprocessing life science company that develops and commercializes consumable products for manufacturing biological drugs. The company's products include Protein A affinity resins, Protein A ligands, ELISA kits, alternating tangential flow system, OPUS …
  • Baoding Lightway Green Energy Technology Co Ltd:企業の戦略的SWOT分析
    Baoding Lightway Green Energy Technology Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • North Pacific Bank,Ltd:企業の戦略・SWOT・財務情報
    North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report Summary North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cancer Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Cancer Research Institute (CRI) is a non-profit cancer research organization that discovers and develops immunotherapy for treating various types of cancer. The organization offers clinical trials for breast cancer, colorectal cancer, lung cancer, melanoma and prostate cancer. Its programs c …
  • Tupperware Brands Corporation:企業の戦略・SWOT・財務情報
    Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Actinium Pharmaceuticals Inc (ATNM):製薬・医療:M&Aディール及び事業提携情報
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • Sectra AB (SECT B):企業の財務・戦略的SWOT分析
    Sectra AB (SECT B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • MAB Discovery GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary MAB Discovery GmbH (MAB Discovery) is a drug discovery and development company that offers novel antibody therapeutics. The company produces monoclonal antibodies derived from rabbits and rats by employing biochemical and cellular based screens. It relies on natural immune response and B cel …
  • New York Power Authority:電力:M&Aディール及び事業提携情報
    Summary New York Power Authority (NYPA) is a state-owned power organization. It generates electricity, and transmits and sells that on wholesale basis. The authority produces the electricity using hydro, gas, and oil sources. Through long-term electricity supply agreement with Astoria Energy II LLC, …
  • Samsung Fire & Marine Insurance Co., Ltd.:企業の戦略・SWOT・財務情報
    Samsung Fire & Marine Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Fire & Marine Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Wirtgen GmbH:企業の戦略・SWOT・財務分析
    Wirtgen GmbH - Strategy, SWOT and Corporate Finance Report Summary Wirtgen GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cellular Biomedicine Group Inc (CBMG):企業の財務・戦略的SWOT分析
    Summary Cellular Biomedicine Group Inc (CBMG) is a clinical stage biopharmaceutical firm that develops biomedicine, immunotherapy products for cancer and stem cell therapies to address patient specific medical conditions. The firm’s products comprise clinical treatment protocols for the treatment of …
  • BioRap Technologies Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BioRap Technologies Ltd (BioRap) is a technology transfer company that offers biomedical solutions for contemporary health care industry. The company’s technologies are used in the treatment of macular disease, alopecia, cardiovascular disease, cancer and autoimmune diseases, cancer therapy, …
  • Naftogaz of Ukraine:企業の戦略的SWOT分析
    Naftogaz of Ukraine - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • LIncoln Electric Holdings Inc:企業のM&A・事業提携・投資動向
    LIncoln Electric Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LIncoln Electric Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Pratt Industries Inc:戦略・SWOT・企業財務分析
    Pratt Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Pratt Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Oxford Biodynamics Plc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neu …
  • Hess Corporation (HES)-エネルギー分野:企業M&A・提携分析
    Summary Hess Corporation (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, Equatorial Guinea, the Joint Development Area of Malaysia/Thailand (JDA), Malaysia, and Norway. It offers fee-ba …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆